Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
June 23, 2026Download PDF Story at-a-glance GLP-1 drugs such as Ozempic and Wegovy have been linked to serious vision concerns, including diabetic retinopathy and optic nerve damage that can result in lasting vision loss Research suggests the highest risk of sudden vision loss may occur within the first year of starting these drugs, with symptoms sometimes appearing overnight without pain or warning Case reports document that even healthy adults using GLP-1 drugs for weight loss with no history of diabetes or eye disease have experienced lasting vision loss Sudden changes in vision such as blurriness, blind spots, or loss of color perception may be early warning signs of optic nerve damage
Ozempic (semaglutide) is an FDA-approved subcutaneous injection for managing blood glucose levels in type 2 diabetes as an adjunct to diet and exercise
According to FDA, GLP-1RA had not shown evident risk of pancreatitis and pancreatic tumor (111)
It is more than a beauty or wellness drip
The response rate proved equally impressive: 91.7% of participants at the 12mg dose achieved at least 10% weight loss, and the majority achieved 15% or greater
